The effect of mentholated cigarette use on interleukin-6 responses across different HIV positive race/ethnic subgroups

International Journal of Interferon, Cytokine and Mediator Research

Volumn 2, Issue 1, 2010, Pages 157-164

  Míguez Burbano, María José ^a   Rosenberg, Rhonda ^a   Malow, Robert ^a   Burbano, Ximena ^c   Devieux, Jessy ^a   Madhavan, Nair ^b  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c Zilonis Health Care Research   (United States)

Author keywords

Aids; Interleukins; Menthol cigarettes; Race ethnicity; Smoking

Indexed keywords

ANTIRETROVIRUS AGENT; CIGARETTE SMOKE; INTERLEUKIN 6; PENICILLIN G; STREPTOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC AND RACIAL GROUPS; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; RISK FACTOR; VIRUS LOAD;

EID: 78649361275     PISSN: None     EISSN: 1179139X     Source Type: Book Series    
DOI: 10.2147/IJICMR.S12392     Document Type: Article

References (39)

1. Liu Y, Berthier-Schaad Y, Fallin MD, et al. IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. [Erratum appears in J Am Soc Nephrol. 2006;17(11):3264]. J Am Soc Nephrol. 2006;17(3):863-870.
2. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-334.
3. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002;22:1668-1673.
4. Enewold L, Mechanic LE, Bowman ED, et al. Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2009;18(1): 215-222.
5. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med. 2002;252(4):283-294.
6. Lowe GD. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol. 2001;6(1):1-8.
7. Saijo Y, Yoshioka E, Fukui T, et al. Effects of the interaction between interleukin-6 -634C/G polymorphism and smoking on serum C-reactive protein concentrations. Hypertens Res. 2007;30:593-599.
8. Friedlander Y, Kark JD, Sinnereich R, Tracy RP, Siscovick DS. Fibrinogen and CRP in Israeli families, genetic and environmental sources of concentrations and longitudinal changes. Atherosclerosis. 2006;189:167-177.
9. Karakas M, Baumert J, Greven S, Rückerl R, Peters A, Koenig W. Reproducibility in serial C-reactive protein and interleukin-6 measurements in post-myocardial infarction patients: results from the AIRGENE study. Clin Chem. 2010;56(5):861-864.
10. Sunyer J, Forastiere F, Pekkanen J, et al; AIRGENE Study Group. Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers. Nicotine Tob Res. 2009;11(11):1347-1353.
11. Neuhaus J, Jacobs D, Baker J, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010;201:1788-1795.
12. Okuyemi KS, Ebersole-Robinson M, Nazir N, Ahluwalia JS. African- American menthol and nonmenthol smokers: differences in smoking and cessation experiences. J Natl Med Assoc. 2004;96(9):1208-1211.
13. Gandhi KK, Foulds J, Steinberg MB, Lu SE, Williams JM. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract. 2009;63(3): 360-367.
14. Gundersen DA, Delnevo CD, Wackowski O. Exploring the relationship between race/ethnicity, menthol smoking, and cessation, in a nationally representative sample of adults. Prev Med. 2009;49(6):553-557. Epub 2009 Oct 19.
15. Unger JB, Allen B Jr, Leonard E, Wenten M, Cruz TB. Menthol and non-menthol cigarette use among Black smokers in Southern California. Nicotine Tob Res. 2010;12(4):398-407.
16. Giovino GA, Sidney S, Gfroerer JC, et al. Epidemiology of menthol cigarette use. Nicotine Tob Res. 2004;6 Suppl 1:S67-S81.
17. Abolhassani M, Guais A, Chaumet-Riffaud P, Sasco AJ, Schwartz L. Carbon dioxide inhalation causes pulmonary inflammation. Am J Physiol Lung Cell Mol Physiol. 2009;296(4):L657-L665. Epub 2009 Jan 9.
18. Moreira Guimarães MM, Bartolomeu Greco D, Ingles Garces AH, de Oliveira AR Jr, Bastos Fóscolo R, de Campos Machado LJ. Coronary heart disease risk assessment in HIV-infected patients: a comparison of Framingham, PROCAM, and SCORE risk assessment functions. Int J Clin Pract. 2010;64(6):739-745.
19. Szczech LA. Monitoring HIV patients' kidney function in clinical practice. What is known about kidney disease in other clinical contexts can help guide HIV care providers in monitoring kidney function in their patients. AIDS Clin Care. 2009;21(11):92-94.
20. Vance DE, Mugavero M, Willig J, Raper JL, Saag MS. Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. J Assoc Nurses AIDS Care. 2010 May 13. [Epub ahead of print].
21. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. 2008 Nov 3. Available at: http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm121604.htm
22. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT. Available at: http://whqlibdoc.who.int/hq/2001/WHO_MSD_MSB_01.6a.pdf
23. Thomas McLellan, Deni Carise, Thomas H Coyne. Addiction Severity Index. 5th ed. Available at: http://www.densonline.org/DENSASI.pdf
24. NIAAA and American Association guidelines. Available at http://rethinkingdrinking.niaaa.nih.gov/IsYourDrinkingPatternRisky/WhatsAtRiskOrHeavyDrinking.asp. Accessed: June 20, 2010.
25. Kunze M, Groman E, Kunze U. Tobacco consumption and tobaccorelated diseases. J Mens Health. 2004;1(1):83-87.
26. Hutchins S, Fiscella K, Levine RS, Ompad DC, McDonald M. Protection of racial/ethnic minority populations during an influenza pandemic. Am J Public Health. 2009;99(S2):S261-S270.
27. Giordano TP, Bartsch G, Zhang Y, et al. Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial. AIDS Patient Care STDS. 2010; 24(5):287-295.
28. Velez DR, Menon R, Thorsen P, et al. Ethnic differences in interleukin 6 (IL-6) and IL6 receptor genes in spontaneous preterm birth and effects on amniotic fluid protein levels. Ann Hum Genet. 2007; 71(Pt 5):586-600.
29. Allison M, Criqui M, McClelland R, et al. The Effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2006;48(6):1190-1197.
30. Narkiewicz K, van de Borne PJ, Hausberg M, et al. Cigarette smoking increases sympathetic outflow in humans. Circulation. 1998;98(6): 528-534.
31. Stengel B, Couchoud C, Cénée S, Hémon D. Age, blood pressure, and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int. 2000;57(6):2519-2526.
32. Wesson DE. The relationship of cigarette smoking to end-stage renal disease. Semin Nephrol. 2003;23(3):317-322.
33. Kuller LH, Tracy R, Belloso W, Wit SD, Drummond F, et al. (2008) Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection. PLoS Med 5(10): e203. doi:10.1371/journal.pmed.0050203
34. Jha AK, Shlipak MG, Hosmer W, Frances CD, Browner WS. Racial differences in mortality among men hospitalized in the veterans affairs health care system. JAMA. 2001;285:297-303.
35. Barnes KC. Genetic determinants and ethnic disparities in sepsis-associated acute lung injury. Proc Am Thorac Soc. 2005;2(3): 195-201.
36. Fellay J. Host genome influences on HIV-1 disease. Antivir Ther. 2009; 14(6):731-738.
37. Ness R, Haggerty C, Harger G, Ferrell R. Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. Am J Epidemiol. 2004;160(11):1033-1038.
38. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372(9639): 669-684.
39. Cohen M, Hellmann N, Levy J, DeCock K, Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest. 2008;118(4):1244-1254.